APOTHEEK SEYNHAVE: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
APOTHEEK SEYNHAVE
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€186,468
2024 · €171,692+€14,776
Equity
€1.8m
2024 · €1.7m+€56,277
Cash
€668,193
2024 · €628,296+€39,896
Balance sheet total
€2.1m
2024 · €2.0m+€51,500
Largest movements
Assets
- Cash +€39,896
up €39,896 (+6.3%), from €628,296 to €668,193
mainly Net result for the year (+€186,468) and Other debts (+€5,224)
Equity and liabilities
- Reserves +€56,277
up €56,277 (+3.9%), from €1.4m to €1.5m
Income statement
- Gross operating margin +€53,554
up €53,554 (+11.6%), from €459,970 to €513,524
- Staff costs +€13,667
up €13,667 (+6.6%), from €207,745 to €221,412
- Financial income -€13,240
down €13,240 (-37.1%), from €35,647 to €22,407
- Taxes +€7,098
up €7,098 (+8.9%), from €80,126 to €87,224
- Write-downs +€6,076
new in 2025: €6,076
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
€171,692
Gross operating margin
+€53,554
Staff costs
-€13,667
Depreciation
+€1,772
Write-downs
-€6,076
Other operating charges
+€18
Financial income
-€13,240
Financial charges
-€485
Taxes
-€7,098
Result 2025
€186,468
raises the resultlowers the result
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
+€170,088
Investment
€0
Financing
-€130,192
Cash 2024
€628,296
From operations (derived)
+€170,088
Net result for the year
+€186,468
Depreciation
+€3,092
Stocks and contracts
-€10,112
Receivables within one year
-€3,550
Deferred charges and accrued income
-€1,033
Trade debts
+€5,130
Tax, wage and social debts
-€14,854
Other debts
+€5,224
Accrued charges and deferred income
-€277
Financing
-€130,192
Contributions, distributions and other
-€130,192
Cash 2025
€668,193
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €2,036,023 | €2,087,523 | +€51,500 | +2.5% |
| Fixed assets | 21/28 | €8,546 | €5,454 | -€3,092 | -36.2% |
| Tangible fixed assets | 22/27 | €8,546 | €5,454 | -€3,092 | -36.2% |
| Plant, machinery and equipment | 23 | €7,922 | €5,454 | -€2,469 | -31.2% |
| Furniture and vehicles | 24 | €623 | - | -€623 | |
| Current assets | 29/58 | €2,027,477 | €2,082,069 | +€54,592 | +2.7% |
| Stocks and contracts in progress | 3 | €233,119 | €243,231 | +€10,112 | +4.3% |
| Stocks | 30/36 | €233,119 | €243,231 | +€10,112 | +4.3% |
| Amounts receivable within one year | 40/41 | €144,772 | €148,322 | +€3,550 | +2.5% |
| Trade receivables | 40 | €126,607 | €141,073 | +€14,466 | +11.4% |
| Other amounts receivable | 41 | €18,165 | €7,249 | -€10,916 | -60.1% |
| Current investments | 50/53 | €1,000,000 | €1,000,000 | = | 0.0% |
| Cash at bank and in hand | 54/58 | €628,296 | €668,193 | +€39,896 | +6.3% |
| Deferred charges and accrued income | 490/1 | €21,290 | €22,323 | +€1,033 | +4.9% |
| Total equity and liabilities | 10/49 | €2,036,023 | €2,087,523 | +€51,500 | +2.5% |
| Equity | 10/15 | €1,698,232 | €1,754,509 | +€56,277 | +3.3% |
| Contributions | 10/11 | €265,000 | €265,000 | = | 0.0% |
| Reserves | 13 | €1,433,232 | €1,489,509 | +€56,277 | +3.9% |
| Distributable reserves | 133 | €1,433,232 | €1,489,509 | +€56,277 | +3.9% |
| Amounts payable | 17/49 | €337,791 | €333,014 | -€4,777 | -1.4% |
| Amounts payable within one year | 42/48 | €310,000 | €305,500 | -€4,500 | -1.5% |
| Trade debts | 44 | €93,133 | €98,264 | +€5,130 | +5.5% |
| Suppliers | 440/4 | €93,133 | €98,264 | +€5,130 | +5.5% |
| Taxes, remuneration and social security | 45 | €66,890 | €52,036 | -€14,854 | -22.2% |
| Taxes | 450/3 | €39,191 | €24,112 | -€15,079 | -38.5% |
| Remuneration and social security | 454/9 | €27,698 | €27,924 | +€225 | +0.8% |
| Other amounts payable | 47/48 | €149,976 | €155,200 | +€5,224 | +3.5% |
| Accrued charges and deferred income | 492/3 | €27,791 | €27,514 | -€277 | -1.0% |
| Remuneration, social security and pensions | 62 | €207,745 | €221,412 | +€13,667 | +6.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €4,864 | €3,092 | -€1,772 | -36.4% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | - | €6,076 | +€6,076 | |
| Other operating charges | 640/8 | €1,400 | €1,381 | -€18 | -1.3% |
| Gross operating margin | 9900 | €459,970 | €513,524 | +€53,554 | +11.6% |
| Operating profit (loss) | 9901 | €245,962 | €281,562 | +€35,600 | +14.5% |
| Financial income | 75/76B | €35,647 | €22,407 | -€13,240 | -37.1% |
| Recurring financial income | 75 | €35,647 | €22,407 | -€13,240 | -37.1% |
| Financial charges | 65/66B | €29,791 | €30,277 | +€485 | +1.6% |
| Recurring financial charges | 65 | €29,791 | €30,277 | +€485 | +1.6% |
| Profit (loss) for the period before taxes | 9903 | €251,818 | €273,692 | +€21,874 | +8.7% |
| Income taxes | 67/77 | €80,126 | €87,224 | +€7,098 | +8.9% |
| Profit (loss) for the period | 9904 | €171,692 | €186,468 | +€14,776 | +8.6% |
| Profit (loss) for the period to be appropriated | 9905 | €171,692 | €186,468 | +€14,776 | +8.6% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 18 October 2026 via checked.be.